Maintenance therapy with selinexor may extend progression-free survival for some endometrial cancer patients
In patients with wild-type TP53 advanced or recurrent endometrial cancer, the addition of maintenance therapy with selinexor…
Browsing: selinexor
EHA 2023: Selinexor subgroup data from the BOSTON trial highlights its clinical potential in R/R Multiple Myeloma
The Menarini Group (“Menarini”), announced important new data on selinexor at the European Hematology Association (EHA) Congress 2023.…
Researchers discover genes that predict good response to blood cancer therapy
Mount Sinai researchers have for the first time identified genes that predict a good response…
Promising treatment for deadly brain cancer
A clinical trial has found that selinexor, the first of a new class of anti-cancer…
FDA approves selinexor for relapsed/refractory diffuse large B-cell lymphoma
The Food and Drug Administration (FDA) granted accelerated approval to selinexor for adult patients with…
Drugs reprogram genes in breast tumours to prevent endocrine resistance
Treating breast tumours with two cancer drugs simultaneously may prevent endocrine resistance by attacking the…